IVVD
Price:
$0.7014
Market Cap:
$83.90M
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. T...[Read more]
Industry
Biotechnology
IPO Date
2021-08-06
Stock Exchange
NASDAQ
Ticker
IVVD
According to Invivyd, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -21337338.00. This represents a change of -115.50% compared to the average of 137.70M of the last 4 quarters.
The mean historical Enterprise Value of Invivyd, Inc. over the last ten years is 694.25M. The current -21337338.00 Enterprise Value has changed -407.35% with respect to the historical average. Over the past ten years (40 quarters), IVVD's Enterprise Value was at its highest in in the September 2021 quarter at 2.11B. The Enterprise Value was at its lowest in in the December 2021 quarter at -232793616.10.
Average
694.25M
Median
247.56M
Minimum
74.05M
Maximum
2.21B
Discovering the peaks and valleys of Invivyd, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 214.73%
Maximum Annual Enterprise Value = 2.21B
Minimum Annual Increase = -88.13%
Minimum Annual Enterprise Value = 74.05M
Year | Enterprise Value | Change |
---|---|---|
2023 | 233.06M | 214.73% |
2022 | 74.05M | -71.74% |
2021 | 262.06M | -88.13% |
The current Enterprise Value of Invivyd, Inc. (IVVD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
189.72M
5-year avg
694.25M
10-year avg
694.25M
Invivyd, Inc.’s Enterprise Value is less than Exscientia plc (0), less than Recursion Pharmaceuticals, Inc. (405.67M), less than Atea Pharmaceuticals, Inc. (1.26B), less than Unity Biotechnology, Inc. (188.01M), less than Icosavax, Inc. (31.01M), less than REGENXBIO Inc. (713.87M), less than Anebulo Pharmaceuticals, Inc. (502.58M), less than Abeona Therapeutics Inc. (36.46M), less than Black Diamond Therapeutics, Inc. (267.34M), less than Generation Bio Co. (139.97M), less than Kronos Bio, Inc. (163.63M), less than Erasca, Inc. (5.32M), less than C4 Therapeutics, Inc. (747.42M), less than Edgewise Therapeutics, Inc. (307.45M), less than Passage Bio, Inc. (3.01B), less than Magenta Therapeutics, Inc. (24.72M), greater than TRACON Pharmaceuticals, Inc. (-114170976.00), less than Aptevo Therapeutics Inc. (-6162490.00), less than null (2.77M),
Company | Enterprise Value | Market cap |
---|---|---|
0 | $632.93M | |
405.67M | $1.59B | |
1.26B | $284.64M | |
188.01M | $19.21M | |
31.01M | $769.04M | |
713.87M | $475.14M | |
502.58M | $37.86M | |
36.46M | $259.96M | |
267.34M | $143.73M | |
139.97M | $91.51M | |
163.63M | $54.49M | |
5.32M | $763.36M | |
747.42M | $300.00M | |
307.45M | $3.05B | |
3.01B | $31.19M | |
24.72M | $42.44M | |
-114170976.00 | $107.51K | |
-6162490.00 | $5.70M | |
2.77M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Invivyd, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Invivyd, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Invivyd, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Invivyd, Inc. (IVVD)?
What is the 3-year average Enterprise Value for Invivyd, Inc. (IVVD)?
What is the 5-year average Enterprise Value for Invivyd, Inc. (IVVD)?
How does the current Enterprise Value for Invivyd, Inc. (IVVD) compare to its historical average?